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Abstract
Background: Metabolic changes in the host in response to Plasmodium infection play a crucial role in the 
pathogenesis of malaria. Alterations in metabolism of male and female mice infected with Plasmodium berghei ANKA 
are reported here.
Methods: 1H NMR spectra of urine, sera and brain extracts of these mice were analysed over disease progression using 
Principle Component Analysis and Orthogonal Partial Least Square Discriminant Analysis.
Results: Analyses of overall changes in urinary profiles during disease progression demonstrate that females show a 
significant early post-infection shift in metabolism as compared to males. In contrast, serum profiles of female mice 
remain unaltered in the early infection stages; whereas that of the male mice changed. Brain metabolite profiles do not 
show global changes in the early stages of infection in either sex. By the late stages urine, serum and brain profiles of 
both sexes are severely affected. Analyses of individual metabolites show significant increase in lactate, alanine and 
lysine, kynurenic acid and quinolinic acid in sera of both males and females at this stage. Early changes in female urine 
are marked by an increase of ureidopropionate, lowering of carnitine and transient enhancement of asparagine and 
dimethylglycine. Several metabolites when analysed individually in sera and brain reveal significant changes in their 
levels in the early phase of infection mainly in female mice. Asparagine and dimethylglycine levels decrease and 
quinolinic acid increases early in sera of infected females. In brain extracts of females, an early rise in levels is also 
observed for lactate, alanine and glycerol, kynurenic acid, ureidopropionate and 2-hydroxy-2-methylbutyrate.
Conclusions: These results suggest that P. berghei infection leads to impairment of glycolysis, lipid metabolism, 
metabolism of tryptophan and degradation of uracil. Characterization of early changes along these pathways may be 
crucial for prognosis and better disease management. Additionally, the distinct sexual dimorphism exhibited in these 
responses has a bearing on the understanding of the pathophysiology of malaria.
Background
Plasmodium is the causative organism of malaria which
affects 200-300 million people and causes nearly one mil-
lion deaths annually [1]. This poses a serious, global
health problem. The clinical symptoms of this parasitic
infection are seen during the blood stages [2].
During the acute stages of the disease more than one
tissue type of the host is known to be affected [2,3]. In
severe cases of Plasmodium falciparum infection, para-
sitized red cells are seen to exhibit sequestration, which
in turn affect the microvasculature in various tissues such
as heart, eyes, liver, kidneys, intestines, and adipose tissue
[4-6] possibly resulting in localized metabolic stress. As
the disease approaches late stages, several complications
accumulate possibly through inflammatory immune
responses and manifest themselves into one or more con-
ditions, such as liver damage, cerebral malaria, renal
damage, severe anaemia, hypoglycaemia and acidosis,
which are often causes of death [7-9]. The transition into
these conditions is incompletely understood and there
are no reliable predictors for them presently. However, all
these manifestations of the disease are associated with
drastic metabolic alterations in the host. Therefore,
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metabolites in body fluids and tissues that correlate with
progression of the disease may serve as useful indicators
of these changes. These metabolites may underscore the
metabolic pathways that are perturbed in the host in
response to infection.
1H NMR spectroscopy of tissues and bio-fluids fol-
lowed by multivariate analyses of the spectroscopic data
is a systems biological approach that has been used to
identify important changes in metabolism [10]. 1H NMR
spectra of such samples provide an unbiased profile of all
metabolites. The strategy has been used to study various
disease conditions including breast cancer, diabetes, cor-
onary heart disease and high blood pressure [11-14].
Metabolic responses of living systems to genetic modifi-
cation, environmental changes and drug-toxicity have
also been studied in various animal models with this
approach [15,16]. Furthermore, parasitic infections, such
as that induced by trypanosomes and schistosomes, have
been investigated in mouse models and relevant metabo-
lites linked with the disease have been identified [17-20].
Composition of bio-fluids and tissues reflects the meta-
bolic status of a living system. In the study here adult male
and female BALB/c mice were infected with Plasmodium
berghei and  1H NMR spectra of urine samples, sera and
whole brain extracts were analysed. This is an experimen-
tal model of non-cerebral malaria (NCM), identical to the
one used in a previous study [3]. Host metabolic alterations
have been characterized in this system. The experiments
using urine samples helped to non-invasively track the
same animals over the progression of the disease. The sera
and brain extracts were useful in further characterizing the
early and late phase metabolic changes during malaria. All
the spectra were analysed using Principal Component
Analysis (PCA) and Orthogonal Partial Least Square-Dis-
criminant Analysis (OPLS-DA) algorithms to elucidate the
identity of metabolites that change with the progress of the
disease. The results of these experiments are presented
here. It is clearly demonstrated that the response of male
and female mice to Plasmodium infection is different in its
temporal nature and degree. In addition, the metabolites
perturbed in the urine, serum and brain exhibit distinct
sex-specific dimorphism. This would have implications in
the pathophysiological susceptibility differences of males
and females to malaria.
Methods
Animal experiments
The animals used in the study were treated in accordance
with the guidelines of the Local Animal Ethics Commit-
tee of TIFR.
Urine sample collection
Eighteen inbred BALB/c mice; aged 6 to 8 weeks were
used. The experiments were conducted in three batches.
Each batch had three male and three female mice belong-
ing to the same litter. Each mouse was housed individu-
ally in a metabolic cage (Tecniplast, Italy) that was
suitably modified for BALB/c mice. The mice were kept
under stable environmental conditions (12-hour day-
night cycle, 22 ± 2°C) with free access to water and stan-
dard food pellets. Mice were acclimatized to the cages for
seven days. In two of the three batches, on the 7th day, two
male and two female mice of the litter were injected intra-
peritoneally with 106 P. berghei (ANKA strain) infected
erythrocytes. All six mice were monitored for 12-14 days
post-infection. In the third batch, all six mice were
housed in the cages for the entire duration without infec-
tion. Each day a 24-hour urine sample for each mouse
was collected from the collecting tube at the bottom of
the metabolic cage between 1500 and 1700 hours. Cages
were cleaned daily to avoid contamination in the next
sample. The collecting tube contained 100 μL of 1%
sodium azide to prevent microbial growth and samples
were stored at -20°C as described below. Such a proce-
dure would average out diurnal variations and stress
related transient changes in the urine composition. Since
animals used for comparison were littermates and were
subjected to the same diet and laboratory environment,
minimal metabolic differences over the period of 21 days
were expected for control uninfected mice of the same
sex. Also when mice of the same sex were compared
before and after infection, it was presumed the changes
observed would be solely due to the disease. Parasitaemia
was monitored in the infected mice by taking tail bleeds,
and examining Giemsa-stained blood-smears [21]. The
schematics of the experimental paradigm and the prog-
ress in parasitaemia in the experiments are shown in Fig-
ure (1A and 1B). Beyond day 13 post-infection, the
parasitaemia rises beyond 30% and mice died after 4-6
days.
Serum and brain sample collection
Twenty-four inbred BALB/c mice (12 male, 12 female)
aged 6 to 8 weeks were used. Eight male and eight female
mice were injected intra-peritoneally with 106 infected
erythrocytes. On day 5 post-infection, eight infected mice
(four male, four female, %parasitaemia = 2.45 ± 0.70
males, 1.53 ± 0.35 females) and four uninfected mice (two
male, two female) were sacrificed by placing them in an
ether chamber. The animals were immediately dissected.
Blood was collected into Eppendorf tubes directly by
heart puncture and allowed to clot. Also, the whole brain
was extracted, snap-frozen in liquid nitrogen and stored
at -80°C until further processing. This procedure was
repeated for the remaining animals on day 13 post-infec-
tion (%parasitaemia = 27.03 ± 5.57 males, 27.13 ± 10.76
females). The experimental scheme is shown in Figure
2A.Basant et al. Malaria Journal 2010, 9:110
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Sample preparation
Urine
Samples were mixed with 0.2 M phosphate buffer (pH
7.4) to make the volume ~750 μL and centrifuged. The
supernatant was stored at -20°C until further use for
NMR spectroscopy. To prepare samples for NMR experi-
ments 40 μL of 0.12% 2, 2-dimethyl-2-silapentane-5-sul-
fonic acid (DSS) in D2O was added to 460 μL of the urine
sample such that DSS (for chemical shift reference) was
present to the extent of 0.01% in the NMR sample.
Serum
Fresh blood samples were incubated at 37°C for 10 min-
utes and subsequently centrifuged at 13,100 g for 10 min-
utes. Perchloric acid was added (final concentration 5%)
to the supernatant. The samples were centrifuged at
11,300 g at 4°C. The supernatants were neutralized using
50% KOH and recentrifuged at 11,300 g. The residues
were discarded and the supernatants were dried in a
speedvac and stored at -20°C. The samples were reconsti-
tuted for NMR experiments in D2O containing DSS at
0.01%.
Brain
Each whole brain was thawed and homogenized in phos-
phate buffer saline (137 mM NaCl, 2.7 mM KCl, 4.3 mM
Na2HPO4, 1.47 mM KH2PO4, pH 7.4) using a glass
homogenizer. To the homogenate was added perchloric
acid (final concentration of 5%) followed by three freeze-
thaw cycles and sonication on ice (4 cycles, high, 10 sec
"on", 1 min "off"). The sample was then centrifuged at
1,811 g for 30 minutes at 4°C. The supernatant was neu-
tralized using 50% KOH and recentrifuged. The residue
was discarded and the supernatant was dried in a speed-
vac and stored at -20°C. The samples were reconstituted
for NMR experiments in D2O containing DSS at 0.01%.
1H NMR spectroscopy
Urine spectra
1D 1H NMR spectra of the urine samples were acquired
on AVANCE 500 MHz Bruker spectrometer with broad-
band inverse probe using DSS as an internal standard and
D2O as the frequency lock at 300 K. The pulse sequence
used included an excitation sculpting routine for the sup-
pression of the water signal. 64 transients were collected
into 8192 data points (TD) using a spectral width of 12.01
ppm resulting in an acquisition time of 0.68 s. A relax-
ation delay of 1 s was used between consecutive pulses
leading to a repetition time of 1.68 s. The FIDs were sub-
jected to exponential multiplication causing additional
Figure 1 Mouse experiments with malarial infection: experiment, parasitaemia and 1H NMR based PCA of urine. A. Each experiment consist-
ed of 3 males (m) and 3 females (f) BALB/c mice of the same litter, housed in individual metabolic cages. The mice were daily sampled for urine for 20 
days (13 days post-infection). The arrow indicates the day of infection with Plasmodium berghei ANKA. B. The average parasitaemia profile of the mice 
as a function of disease progression. C. A representative scores plot showing the trajectory of a single infected animal. Each point corresponds to the 
day indicated. Black circle = pre-infection, Red triangle = post-infection. The ellipse is a 95% Hotelling's T2 ellipse. R2X (cum) = 0.794 (male), 0.829 (fe-
male).
-0.4
0.0
0.4
-0.8 -0.4 -0.0 0.4 0.8
P
C
 
2
PC 1
d-6
d-4
d-3
d-2
d-1
d0
d3
d4
d5
d6
d8
d9
d10
d11
d12
d14
d1
Parasitemia profile
0.0
10.0
20.0
30.0
40.0
d2 d4 d6 d8 d10 d12
days post infection
%
 
p
a
r
a
s
i
t
e
m
i
a males
females
-0.4
-0.2
-0.0
0.2
0.4
-0.6 -0.4 -0.2 -0.0 0.2 0.4 0.6
 
P
C
 
3
PC 1
d-6
d-5 d-4d-3
d-2 d-1
d0
d3
d4
d5
d6
d7
d8 d9
d10 d11
d12
d1
d2
B
C male female
d13 Mouse 3
m/f
A
Mouse 2
m/f
Mouse 1
m/f
d13 d0 pre-infection post-infection
infection
d-6 d13 d0 pre-infection post-infection
infection
d0 no infection no infection
d-6
d-6Basant et al. Malaria Journal 2010, 9:110
http://www.malariajournal.com/content/9/1/110
Page 4 of 13
line-broadening of 0.2 Hz. A sine bell apodization func-
tion was also applied prior to Fourier transformation. In
order to identify the metabolites, 2D NMR 1H-1H corre-
lation spectroscopy (COSY) and total correlation spec-
troscopy (TOCSY) experiments were conducted on
selected samples. In both these experiments, 32 tran-
sients per increment and 256 increments were collected
in the indirect dimension. A QSINE function with 2048
and 1024 digital points were used for processing the 2D
COSY. The TOCSY data was processed using SINE func-
tion. For both the datasets exponential multiplication of
0.20 and 0.30 Hz in the direct and indirect dimension
respectively were used. In addition, a Gaussian multipli-
cation of 0.1 Hz in the indirect dimension was applied for
the TOCSY data.
Serum and brain spectra
1D 1H NMR spectra of these samples were acquired on
AVANCE 700 MHz Bruker spectrometer with broad-
band inverse probe using DSS as an internal standard and
D2O as the frequency lock at 300 K. The pulse sequence
used included an excitation sculpting routine for the sup-
pression of the water signal. 1024 transients were col-
lected into 32,768 data points (TD) using a spectral width
of 12.01 ppm resulting in an acquisition time of 1.94 s. A
relaxation delay of 1 s was used between consecutive
pulses leading to a repetition time of 2.94 s. The FIDs
were subjected to exponential multiplication causing
additional line-broadening of 0.2 Hz. A sine bell apodiza-
tion function was also applied prior to Fourier transfor-
mation. In COSY experiments for these samples, 64
transients per increment and 256 increments were col-
lected in the indirect dimension. A QSINE function with
2048 and 1024 digital points were used for processing.
Exponential multiplication of 0.20 and 0.30 Hz in the
direct and indirect dimension respectively was used.
Online databases were used to acquire spectral informa-
tion about relevant metabolites [22].
Data reduction
Spectra were manually phased and baseline corrected.
Spectral region of 0.5 to 9.5 ppm was segmented into fre-
quency bins of 0.04 ppm for each spectrum and each bin
was integrated using MestReC 4.7.0. The region corre-
sponding to water and urea (4.5 to 6.5 ppm) was excluded
during binning to avoid artifacts due to pre-saturation of
water and the highly variable urea. Certain regions of the
spectrum were found to contain peaks of high concentra-
tion with high variances across spectra/animals, which
bore no correlation with infection. These regions were
overestimated in PCA analyses masking potentially influ-
Figure 2 Mouse experiments with malarial infection: experiment and 1H NMR based OPLS-DA of serum and brain. A. The experiment consist-
ed of 12 males and 12 females. The parasite P. berghei ANKA was injected in 8 males and 8 females on day 0. On day 5 post-infection, 4 uninfected 
controls (2 males, 2 females) and 8 infected animals (4 males, 4 females) were sacrificed and whole brain tissue and serum collected. The remaining 
animals were sacrificed similarly on day 13 post-infection. B. Scores plot of the OPLS-DA model of serum and brain from all 24 animals showing male-
female class separation. R2X(cum), Q2(cum) = 0.506, -0.156 serum; 0.564, -0.278 brain. Temporal metabolic changes in C. serum and D. brain have been 
shown by comparing day 5 (early) and day 13 (late) post-infection with uninfected controls. C. R2X(cum), Q2(cum) = 0.87, 0.531 males, early; 0.994, 
0.983 males, late; 0.744, -0.241 females, early; 0.996, 0.977 females, late D. R2X(cum), Q2(cum) = 0.554, 0.08 males, early; 0.981, 0.991 males, late; 0.698, 
-0.199 females, early; 0.985, 0.933 females, late.
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ential metabolites present in lower concentrations. Exclu-
sion of these regions (3.25 to 3.46 (taurine), 2.82 to 2.89
(trimethylamine), 2.50 to 2.78 (citrate), 1.86 to 1.94 (ace-
tate) ppm) from the initial analyses improved the quality
of the models and allowed us to see differences arising
due to infection more clearly. Such an observation has
been made previously in other studies [17]. The resulting
integrals were normalized to the total intensity of the
spectrum to correct for inter-sample differences in con-
centration using an in-house developed program. For
serum samples, the region from 1.26 to 1.38 ppm was
removed from the data matrix prior to normalization
because this lactate signal showed a pronounced increase
post-infection that masked other changes.
Statistical analyses
Statistical processing and visualization was achieved by
SIMCA-P 12.0 (Umetrics AB, Umea, Sweden).
Urine
Data from different litters was modeled separately to
avoid inter-litter variations. The spectral changes
observed in litters 1 & 2 were however, comparable. PCA
and OPLS-DA models were set up in three ways: (1)
using data for all six mice from a litter (male and female);
(2) using data from three mice of the same sex from a sin-
gle litter; (3) modifying model 2 and using only the fol-
lowing data points (3a) days -2 to 0 and 1 to 4 (3b) days -2
to 0 and 5 to 8 (3c) days -2 to 0 and 9 to ~13. Models of
type (1) establish differences between male and female
samples (2) establish the extent of separation between
uninfected and infected samples within the same sex
cohort and (3) establish whether there is an increasing
metabolic change with the progression of the disease.
Serum and brain
Data from serum and brain were treated separately. In
each case, PCA and OPLS-DA models were set up in the
following ways: (1) using data from all 24 animals (2)
using data from control males and day 5 post-infection
infected males (3) using data from control males and day
13 post-infection infected males (4) using data from con-
trol females and day 5 post-infection infected females (5)
using data from -control females and day 13 post-infec-
tion infected females.
In OPLS-DA models within the same sex cohort, unin-
fected samples were treated as class 1 and infected sam-
ples as class 2. In other models males were treated as class
1 and females as class 2. All spectral data was Pareto
scaled. One predictive component and all significant
orthogonal components were calculated in each model.
For all the PCA and OPLS-DA models, two-dimensional
scores plots aided in visualization and representation of
the sample clustering. In some cases to visualize a scores
plot, a non-significant orthogonal component had to be
calculated. R2X (cum) and Q2 (cum) values from each
model indicated its quality. They represent goodness of
fit and predictability of the model respectively. S-plots
along with loadings and variable importance plots of
OPLS-DA models were used to interpret results and
arrive at the spectral bins causing differences between
classes.
Peak integration
Following the identification of spectral regions and
metabolites of interest, individual 1D NMR spectra were
integrated for specific peaks using TOPSPIN 2.1 soft-
ware. The peak intensities in each spectrum was calcu-
lated relative to the peak height of DSS and normalized to
the total intensity of the spectrum (urine) or the wet
weight of the tissue (serum and brain). Comparisons for
significance were made using Student's t-test.
Results
Unsupervised clustering in urine data
Since urine is the most non-invasive sample, we tracked
urinary changes of the same animals pre- and post-infec-
tion, with average 24-hour samples collected from each
animal over a total of 20 to 22 days (Figure 1A). These
mice were kept individually in metabolic cages and thus,
uninfected mice were also maintained to ascertain that
the stress of stay in metabolic cages for a prolonged
period did not contribute to metabolic imbalance. The
parasitaemia of infected mice was monitored throughout
this period (Figure 1B). For an overview of our dataset, to
determine its quality and to identify samples that are seri-
ous outliers, first Principle Component Analysis was per-
formed. This established in an unsupervised manner,
whether Plasmodium infection changed the metabolism
in the host. It showed that data-points corresponding to
pre- and post-infection days were differentiable from
each other when data for a single animal was visualized
(Figure 1C), indicating that the metabolite profile of the
animal changed with infection. When data from multiple
animals was combined in PCA scores, the post-infection
changes were more difficult to visualize [see additional
file 1]. All subsequent analyses were carried out by a pri-
ori  assignment of samples into classes of either unin-
fected and infected or male and female. This was done by
Orthogonal Partial Least Square Discriminant Analysis
(OPLS-DA).
Difference in male-female urinary metabolic profiles
The initial examination of urine spectra from one batch
o f  u n i n f e c t e d  ( n o r m a l )  m i c e  s h o w e d  v e r y  h i g h  m a l e -
female class segregation (Q2( c u m ) ,  a n  i n d i c a t o r  o f  t h e
predictability of the model = 0.811, Figure 3A). This dif-
ference remained large even in the two batches where
malaria infection was introduced (Q2(cum) = 0.840,
0.922) as also when only late stage infected samples wereBasant et al. Malaria Journal 2010, 9:110
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considered [see additional file 2]. This confirmed that
male and female urinary metabolic profiles are inherently
different in mice. Such metabolically distinct profiles of
urine samples and the contributing metabolites have
been reported in humans and Hans Wistar rats [23,24].
To investigate malaria infection related changes specifi-
cally therefore, data from male and female mice were ana-
lyzed separately.
Changes in urinary metabolic profile with progression of 
disease
Uninfected and infected urine samples were defined as
two classes in the two sets of experiments. They were dis-
tinct (Q2(cum) = 0.321, 0.339 for males; 0.528, 0.576 for
females) from each other in every litter (Figure 3B and
3C). The same distinction was not seen between pre- and
post-day 0 data points in the batch where no mice were
infected (Q2(cum) = -0.022 for males; 0.161 for females),
[see additional file 3]. Both males and females showed a
significant shift from control samples of the same sex
when they were infected. This established that the infec-
tion causes the metabolic profile of infected animals to
change considerably. There was no significant change in
the profile if the mice were not injected with parasite.
Next, statistical models (3a), (3b) and (3c) were con-
structed (see Methods) which captured the early (days 1
to 4), intermediate (days 5 to 8) and late (days 9 to ~13)
stages of infection respectively. These were used to
address two questions. One, whether these metabolic
profile changes became more pronounced when specific
stages of infection were considered (i.e. whether Q2(cum)
values improved). Secondly, to ask if the urinary profiles
of mice became increasingly different as the infection
progressed. Figure 4 shows the typical scores plots of
these models. It was observed that in males, the change
was negligible in early and intermediate stages (Q2(cum)
= -0.126, 0.058 early; -0.371, -0.163 intermediate) as seen
in Figure 4A and 4B. One mouse was found to behave as
an outlier in litter 2 at the early stage of infection and was
therefore excluded during the calculation of that model.
In females however, the metabolic change was apparent
within the first few days post-infection (Q2(cum) = 0.640,
0.227 early; 0.570, 0.574 intermediate), as seen in panels
D and E of Figure 4. The parasitaemia levels of male and
female mice in all stages remained comparable (Figure
1B). In the late stage males showed high differences from
uninfected data with Q2(cum) values of 0.926 and 0.789
(Figure 4C). However females showed a variable trend
(Q2(cum) = 0.837 and 0.335). Data from one of the litters
is plotted in each panel of Figure 4. Beyond day 13 post-
infection, the parasitaemia rises beyond 30% and the
mice die within four to six days.
Perturbed metabolites: urine
In addition to the differences shown in temporal response
to the parasite, male and female mice also showed dis-
tinct differences in the metabolites that were perturbed
with infection in urine upon comparison with control
samples of the same sex. Figure 5 shows a representative
S plot (correlation of spectral bins with infected-unin-
fected class separation) corresponding to the scores plot
of Figure 4C where urine samples from late stage infected
males were compared with control males. Such plots in
Figure 3 1H NMR based OPLS-DA scores of urine of mice with/
without infection with Plasmodium berghei ANKA. A. The model is 
from data of 6 uninfected mice of a litter (3 male, 3 female). Each point 
represents a sample corresponding to a mouse for the day indicated. 
The first number in the label indicates the mouse (1, 2 or 3); orange cir-
cle = male, green triangle = female. R2X (cum), Q2(cum) = 0.645, 0.811. 
B and C. Data from 3 mice (2 infected on day 7) of a litter monitored 
over 22 days, has been modeled in each case. Each point represents a 
mouse corresponding to the day indicated. The first number in the la-
bel indicates the mouse (1 = inf1, 2 = inf2, c = control). Black circle = 
uninfected, Red triangle = infected. R2X (cum), Q2(cum) are B. 0.632, 
0.339, C. 0.73, 0.576. The ellipse is a 95% Hotelling's T2 ellipse.
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conjugation with loadings and variable importance plots
were used to identify relevant spectral regions contribut-
ing to the class segregation. A list of the metabolites that
showed changes in their levels is given in Table 1. The
identification of the metabolites was based on reported
chemical shifts and 2D COSY experiments. The regions
of the spectrum that change were very different between
the sexes, excepting one commonality. The bin at 4.1 ppm
which contained lactic acid was increased in both cases.
This was the most predominant change observed in
females when the late stage of infection was considered,
but not in males. The region of 1.06 ppm showing an
enhancement in females is likely to contain signals from
increased levels of certain steroids, but these occur in
very low concentrations and their presence could not be
confirmed in the spectra.
Females showed a shift in metabolism in the early stage
of infection, which was marked by an increase of ureido-
Figure 4 Representative OPLS-DA scores of 1H NMR spectra of mouse urine showing post-infection temporal changes. A-C male. D-F female. 
Data-points of days -2 to 0 (pre-infection) for 3 mice of a litter have been compared with A, D: days 1 to 4 (early stage infection); B, E: days 5 to 8 (in-
termediate stage infection) and C, F: days 9 to ~13 (late stage infection). Each point represents a sample corresponding to the day indicated. The first 
number in the label indicates the mouse. 1 = inf1, 2 = inf2, c = control. Black circle = uninfected, Red triangle = infected. The ellipse is a 95% Hotelling's 
T2 ellipse. For A and B non-significant orthogonal components had to be calculated. R2X(cum), Q2(cum) = A. 0.569, -0.126; B. 0.531, -0.371; C. 0.925, 
0.926; D. 0.752, 0.64; E. 0.558, 0.57; F. 0.911, 0.837.
-0.4
-0.2
-0.0
0.2
0.4
-0.20 0.00 0.20
1d-2
1d-1 1d0
2d-2
2d-1
2d0
cd3
cd4
cd-2
cd-1
cd0 cd1 cd2
1d3
1d4
1d1
1d2 2d3
2d4
2d1
-0.4
0.0
0.4
-0.4 -0.2 -0.0 0.2 0.4
t
 
o
r
t
h
o
 
[
1
]
1d-2
1d-1
1d0
2d-2
2d-1
2d0
cd3
cd4
cd-2
cd-
cd0
cd1
cd2
1d3
1d1
1d2
2d3
2d4
2d1
2d2
-0.4
-0.2
-0.0
0.2
0.4
-0.4 -0.2 -0.0 0.2 0.4
1d-2
1d-1 1d0
2d-2
2d-1
2d0
cd5
cd6 cd7 cd8
cd-2
cd-1
cd0
1d5
1d6
1d7
1d8
2d5 2d6
2d7 2d8
-0.4
0.0
0.4
-0.20 0.00 0.20
t[1]
1d-2
1d-1
1d0
2d-2
2d-1
2d0
cd9
cd10 cd11
cd12
cd-2 cd-1
cd0
1d9 1d10
1d11
1d12
2d9
2d10
2d11
-0.4
-0.2
-0.0
0.2
0.4
-0.6 -0.4 -0.2 -0.0 0.2 0.4 0.6
t
 
o
r
t
h
o
 
[
1
]
1d-2
1d-1
1d0
2d-2 2d-1
2d0
cd5
cd6
cd7
cd8
cd-2 cd-1
cd0
1d5
1d7
1d8
2d5
2d6
2d7
2d8
B intermediate
A early
F late
E intermediate
D early
males females
-0.126
-0.371
0.926
0.64
0.57
0.837
-0.4
0.0
0.4
-0.4 0.0 0.4
t
 
o
r
t
h
o
 
[
1
]
t[1]
1d-2 1d-1 1d0
2d-2 2d-1
2d0
cd9
cd10
cd11 cd12
cd-2
cd-1
cd0 1d9
1d10
1d11
1d12
2d9 2d10
2d11
2d12
C lateBasant et al. Malaria Journal 2010, 9:110
http://www.malariajournal.com/content/9/1/110
Page 8 of 13
propionic acid and a decrease of carnitine. Reduction in
urine carnitine levels in females at the early infection
time-point was confirmed by individual peak integration
(p = 0.015). These levels remained low even in the late
stage (p = 0.004). However these trends were not
observed in males.
Individual peak integration also revealed other distinc-
tions in post-infection male and female urinary profiles
that were not apparent from OPLS-DA models. It was
observed that in stage-matched infected animals, the
peak belonging to asparagine and DMG showed different
trends in male and female mice [see additional file 4]. In
females, the levels rose in the early stage and became
comparable to controls in the late stage, whereas the lev-
els continuously fell over the period of infection in male
mice. The decrease in alanine and glycerol levels was sig-
nificantly more in males, in both early and late stages of
infection [see additional file 4]. Kynurenic acid levels are
reduced in both males and females in the early stage of
infection, however the decrease in levels is marginally
larger in males (p = 0.08).
Difference in male-female serum and brain metabolic 
profiles
Figure 2B shows the OPLS-DA scores of 1H NMR spectra
of sera and brain extracts of the male and female mice. No
male-female class segregation was observed (Q2(cum) = -
0.156 serum; -0.278 brain). This holds regardless of the
presence or absence of parasitic infection. This was con-
trary to our observation based on 1H NMR spectra of
urine samples. This established that while in the urine,
metabolites were excreted differentially; overall serum
and brain metabolisms were not significantly divergent in
the two sexes.
Changes in serum and brain metabolic profiles with 
progression of disease
In order to investigate if differential temporal changes
occurred in blood and brain, sera and brain samples were
collected at early stage (day 5 post-infection) and late
stage (day 13 post-infection) from animals. OPLS-DA
scores of 1H NMR spectra of these tissue extracts of mice
with progression of infection are shown in Figure 2C and
Figure 5 Representative OPLS-DA S-plot showing relative contribution of bins to clustering of uninfected and infected classes. This plot cor-
responds to scores plot Figure 4C. Red - important bins increased post-infection, Blue - important bins decreased post-infection. Bins with high cor-
relation with class separation (>0.5 for increased, >0.75 for decreased) and high magnitude (>0.15) were selected for further analysis.Basant et al. Malaria Journal 2010, 9:110
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2D. Serum profiles showed a temporal trend that was dif-
fer ent fr om t he urine. When da ta fr om ear ly infection
stage was compared with uninfected controls, the segre-
gation was high in males (Q2(cum) = 0.531) and negligible
in females (Q2(cum) = -0.241). The brain profiles were
unperturbed in the early stages (Q2(cum) = 0.08 males, -
0.199 females). In the late stage, the serum and brain pro-
files changed drastically in both males (Q2(cum) = 0.983
serum, 0.991 brain) and females (Q2(cum) = 0.977 serum,
0.933 brain). A summary of all changes in terms of
Q2(cum) is provided in additional file 5.
Perturbed metabolites: serum and brain
Serum and brain profiles, like those of urine, showed sex-
specific differences in metabolites that were perturbed
with infection. The metabolites identified from urine,
serum and brain OPLS-DA modeling were further inves-
tigated by specific peak integration of individual spectra
to determine changes in their levels over disease progres-
sion and between sexes in the various tissues. An over-
view of confirmed increased and decreased metabolites
in sera and brain extracts are shown in additional file 6.
Metabolites identified by OPLS-DA in serum and brain
showed high overlap with those identified in urine with
the exception of certain aromatic signals which appeared
more prominently in urine. All significant trends for sera
and brain are shown in Figure 6 and are mentioned below.
As is expected in the late stages of a lethal Plasmodium
infection, there were significant alterations in the serum
levels of several metabolites. The levels of kynurenic acid,
quinolinic acid and alanine and lysine were significantly
increased in the sera of both male and female mice (Fig-
ure 6E, I and 6J). Other changes occurred only in female
mice, as shown for lactate, alanine and glycerol, ureido-
propionic acid, glycerol and glycine, and 2-hydroxy-2-
methyl-butyric acid (Figure 6C, F, G and 6H). In the
brain, carnitine levels were found to be significantly
higher in females at this stage (Figure 6B).
The changes in metabolite levels indicated by OPLS-
D A a na lysis i n se r a o f  m a le  m ic e  a t t he  ea r ly s tag e  of
infection did not show significant trends when individual
peaks were integrated. Significant early changes in
metabolite levels were seen predominantly in female mice
(Figure 6). In serum extracts, asparagine and DMG levels
were significantly reduced (Figure 6A). In extracts from
the brain, levels of lactate, asparagine and DMG, alanine
and glycerol, and kynurenic acid were increased only in
females in the early stage of infection (Figure 6A, C, D
and 6E).
Perturbed metabolites: male-female differences during 
disease progression in serum and brain
Direct comparisons of metabolite levels in male and
female mice at both post-infection stages of infection
were also made. Serum levels of quinolinic acid were
higher in females when compared to males in the early
stage of infection (Figure 6I). However in brain extracts
from the same animals, this trend was observed for sev-
eral metabolites namely lactate, asparagine and DMG,
alanine and glycerol, quinolinic acid, ureidopropionic
acid and 2-hydroxy-2-methyl-butyric acid during early
infection (Figure 6A, C, D, F, H and 6I). In the late stage of
infection, females had lower ureidopropionic acid and
higher 2-hydroxy-2-methyl-butyric acid when compared
to males.
Table 1: Urinary metabolites perturbed in mice upon infection with Plasmodium berghei ANKA
Increased Compound Chemical shift VIP value Loading Decreased Compound Chemical shift VIP value Loading
Females early stage
Ureidopropionate 2.34 3.02 +0.228 Carnitine 2.40 2.46 -0.179
Females late stage
Lactate 4.10 2.89 +0.325 Carnitine 2.40 2.74 -0.318
Unidentified 1.06 1.63 +0.188 Unidentified 6.98 1.53 -0.174
Asparagine, DMG 2.90 1.60 +0.177
Males late stage
Creatine 3.90 3.34 +0.409 Unidentified 0.74 2.35 -0.255
Kynurenic acid 7.38 1.79 +0.205 Unidentified 0.70 2.14 -0.253
Phenylacetylglycine 7.38 1.79 +0.205 Unidentified 0.98 2.17 -0.245
GABA, Glutathione, 
Histamine, Oxoglutaric 
acid
3.00 2.20 +0.184 Lysine, Caprylate, Valerate, 
Alanine, Ethylmethyl 
acetate
1.5 1.25 -0.137
Lactate 4.10 1.60 +0.181
Quinolinic acid 7.42 0.94 +0.117Basant et al. Malaria Journal 2010, 9:110
http://www.malariajournal.com/content/9/1/110
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Discussion
The large-scale metabolic phenotyping of malaria-
infected tissues and body fluids carried out in this study
brings into focus several aspects of the host response to
the parasite. This data strongly indicates that male and
female animals respond to the infection in different ways.
Urine profiles of female mice were altered much earlier as
compared to males during disease progression. Serum
profiles on the other hand, showed global changes in
male mice in early infection but not in females. Overall
metabolism changed drastically in the late stages in both
sexes. However, when levels of specific metabolites were
assessed, changes occurred in the early stages in all three
tissues/body fluids investigated, and the data indicates
t h a t  m a j o r i t y  o f  t h e s e  a r e  s e e n  i n  f e m a l e  m i c e .  T h e
metabolites that showed such alterations included carni-
tine, ureidopropionate, asparagine and dimethylglycine,
lactate, quinolinic acid, kynurenic acid, 2-hydroxy-2-
methylbutyrate, alanine and glycerol. They are indicative
of perturbations in multiple pathways including glycoly-
sis, lipid metabolism, tryptophan metabolism and uracil
degradation. Since the responses along these pathways
are more prominent in female mice, these results are
important for understanding the differential pathophysi-
ology of malaria in the two sexes.
Inherent sex differences in urine metabolites have been
documented earlier in rats as well as in humans [23,24].
T he  high va lu es  of  Q 2(cum) in the data reported here
(0.811) and that in humans (0.47) when male versus
female urine samples are compared, suggests a very sig-
nificant divergence in their metabolism [see additional
file 5], [24]. It was also observed that removal of up to
50% spectral bins from the data set in OPLS-DA analysis
failed to change the male-female segregation consider-
ably (Q2(cum) = 0.729). However such sex-specific diver-
gence did not exist in serum and brain tissue metabolites
(Figure 5B, additional file 5). In most murine studies same
sex animals are examined for disease related changes
[17,20,25]. This is the first report of an elaborate compar-
ison of sex related disparity in metabolic changes in
response to a pathogen.
Urine samples represent the global metabolic state of
the host and are non-invasively obtained. Multivariate
analyses of 1H NMR spectra of urine enabled us to visual-
ize temporal changes in the host response and identify
the sexual dimorphism therein. Further, when serum and
brain profiles of infected mice were investigated, brain
metabolism was found to be unaltered in the early stages
when the complete metabolite profile is considered; indi-
cating that brain tissue is largely uninfluenced by the par-
asite at the onset of malaria. The observation that serum
profiles changed early in males, while their urine profiles
did not, raises the possibility that female hosts are able to
Figure 6 Perturbed metabolite levels in mouse serum and brain at early and late stage malarial infection. All peak intensities have been cal-
culated relative to the peak height of 0.132 mg/ml DSS present in every sample. Panels showing two metabolites represent overlapping 1H NMR res-
onances. Black = males, grey = females. * indicates p < 0.05 in comparison to the uninfected control of the same sex. # indicates p < 0.05 in comparison 
to the males of the same infection time-point. S = serum, B = brain.Basant et al. Malaria Journal 2010, 9:110
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regulate their metabolism to maintain homeostasis in the
blood.
The increase in lactic acid reported in this study is
expected since Plasmodium  infection is known to
increase glycolytic rate in RBCs [26-28]. Additionally, a
sexual dimorphism is also observed in serum and brain
levels of lactate (Figure 6C). Since parasitaemia levels are
not significantly different between the two sexes, it is
plausible that the change in lactate levels in females is not
solely due to increased glucose utilization by the parasite
and may reflect enhanced glycolysis in the host. Up-regu-
lation of glycolysis would also lead to enhanced transami-
nation of pyruvate to alanine. Alanine clearance and
alanine to lactate ratio have been correlated with the
severity of clinical malaria [29]. In the data reported here,
the variations in alanine levels parallel those of lactate,
suggesting that these changes may be linked to their com-
mon substrate pyruvate (Figure 6D). Alanine has been
r e p o r t e d  t o  b e  u p - r e g u l a t e d  i n  b r a i n  t i s s u e  o f  f e m a l e
BALB/c mice infected with Plasmodium berghei ANKA
[3].
An imbalance of amino acid metabolism in the disease
process manifests in altered levels of several amino acids
[3,8]. In this study, alanine, lysine, glycine and asparagine
levels are perturbed during disease progression. Lysine
levels are increased in late stage male and female sera. A
previous metabolomic study in malaria has reported
prominent enhancement of pipecolic acid, a neuromodu-
lator formed from the degradation of lysine [30]. This
molecule was not observed in the experiments of this
report possibly due to the difference in strain and age of
animals used. Of particular interest is the observed trend
of asparagine levels in females during early phase of the
disease (increase in urine and brain, decrease in serum).
Plasmodium species incorporate disproportionately large
amount of asparagine in its proteome in the ubiquitous
low complexity regions [31]. However, it is unclear how
this might impact the sex-specific manner in which
asparagine levels change.
Kynurenic acid (KA) and quinolinic acid (QA) were
observed to be enhanced in urine in male infected mice
(Table 1). The variation exhibited a pronounced sexual
dimorphism during early infection when sera and brain
were considered (Figure 6E). Changes in KA and QA have
been implicated in the pathogenesis of cerebral malaria.
They are involved in an oxidative metabolic pathway that
converts tryptophan into kynurenine via IFN-γ activated
indoleamine 2, 3-dioxygenase (IDO). Kynurenine is fur-
ther converted into KA and QA via two divergent path-
w a y s  [ 3 2 ] .  T h e  r a t i o  o f  Q A  t o  K A  i s  r e p o r t e d  t o  b e
i n c r e a s e d  i n  t h e  b r a i n  o f  m i c e  w i t h  c e r e b r a l  m a l a r i a
(CM), but not in non-cerebral malaria (NCM) [32]. Mice
with CM have also been found to survive longer when
this pathway is inhibited [33]. In addition, IDO activity
has also been reported to be up-regulated in the vascular
endothelium of several tissues of mice infected with P.
berghei in a previous study [34]. The set up used here
with BALB/c mice and P. berghei is an NCM model. The
results identify mis-regulation along the kynurenine
pathway in urine, sera and brain. Furthermore, the early
stage alterations are only in females and not in males.
Ureidopropionate is a known intermediate in the
breakdown of uracil to β-alanine. Its accumulation in
body fluids is indicative of a deficiency of ureidopropio-
nase and represents a severe form of propionic aciduria.
Ureidopropionate is an endogenous neurotoxin manifest-
ing in severe neuropathology of the grey and the white
matter [35]. The observed variation in levels of this
metabolite is suggestive of the aforementioned condition.
It remains to be established how the presence of the para-
site influences this pathway selectively in females (Figure
6F). Variations in 2-hydroxy-2-methylbutyrate also exhib-
ited differences in males and females (Figure 6H). In
humans, 2-hydroxy-2-methylbutyrate is found in urine of
patients with 2-hydroxyglutaric aciduria [36]. This condi-
tion is accompanied by cerebellar atrophy and subcortical
leukoencephalopathy. The observed increase of this
metabolite in female brain suggests that females may be
(at least transiently) more prone to such neural degenera-
tion early in the presence of the parasite.
Glycerol levels showed an upward trend that is signifi-
cant in the sera of late stage female mice (Figure 6D and
6G). Fasting glycerol concentrations and turn-over of
infused glycerol in malaria patients has been reported to
be higher than in patients recovering from the disease
[37]. OPLS-DA results in this paper also suggested an
incremental trend in long chain fatty acid concentrations
in serum [see additional file 5] and urine. Oxidation of
these fatty acids would entail the recruitment of carni-
tine. The decrease in carnitine levels in urine observed
solely in females suggests a selectively higher retention of
this metabolite for cellular β-oxidation of fatty acids. This
is in contrast to normal resting situation in humans,
where elevated levels of carnitine and acetylcarnitine in
males relative to females were observed [24]. Dimethylg-
lycine (DMG) is an intermediate derived from choline,
which may be acquired from the diet or through catabo-
lism of phospholipids [38,39]. Higher DMG has been
observed previously in normal female Wistar rats as com-
pared to males [23]. Here an early increase of DMG in
brain tissue, a decrease in sera and a transient rise in
urine levels was observed in females as opposed to males
(Figure 6A). Accumulation of DMG in plasma has been
reported to be an indicator of chronic renal failure [40]. It
remains to be ascertained how the sexual dimorphism
observed in DMG level variation may have a bearing on
renal function.Basant et al. Malaria Journal 2010, 9:110
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Metabolic profiling of several diseases such as sepsis,
those caused by microbial pathogens Streptococcus,
Staphylococcus  and by parasites, such as Trypanosoma
and Schistosoma has been reported [17,20,25,41]. Lactate
and alanine were observed to be altered in sepsis [41],
Trypanosoma [20] and Schistosoma [17] infections. How-
ever, specific alterations reported here in the levels of car-
nitine, asparagine, KA, QA and ureidopropionate appear
to be unique to malarial infection. The pathways involv-
ing these metabolites, specifically those in early
responses may determine the specificity of malaria
pathogenesis and lead to molecular predictors of disease
progression.
Clinically many parasitic diseases have been reported
to affect males and females differentially [42,43]. Males
have been shown to be more susceptible to Plasmodium,
Trypanosoma, Giardia and Leishmania major, while
females are more susceptible to Leishmania donovani,
Trichomonas vaginalis and  Toxoplasma gondii [44]. In
humans, although no sexual dimorphism is observed in
most malaria endemic areas, the intensity of infection is
reported to be higher for males [45]. Studies in adult
mice, exposed for the first time to malaria parasites, have
established a distinct sex-bias with higher susceptibility
in male mice [46,47]. Through a transcriptomic study,
some of the observed differences have been attributed to
differential immune and haematopoietic responses, per-
haps caused by differential hormonal regulation [47]. The
demonstration here of early sensitization of females to
Plasmodium infection establishes sexual dimorphism in
s y s t e m i c  m e t a b o l i c  r e s p o n s e  o f  m i c e  t o  m a l a r i a .  I t  i s
unclear presently how such responses may be modulated
in the host. The data from the present study provide can-
didate metabolites implicating pathways that differ
between the sexes during disease progression. An under-
standing of early events would help towards the elucida-
tion of mechanisms contributing to sexual dimorphism
and severity in malaria.
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